Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GHSR | Q92847 | 6/20 | 0.54 |
| ▸ | ECE1 | P42892 | 2/20 | 0.49 |
| ▸ | NPY1R | P25929 | 3/20 | 0.47 |
| ▸ | NPY2R | P49146 | 3/20 | 0.47 |
| ▸ | NPY4R | P50391 | 3/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30254250 | 0.93 | ACE (0.50) | GHSRECE1 | |
| SCHEMBL31721034 | 0.90 | GHSR (0.54) | GHSR | |
| SCHEMBL30123606 | 0.88 | NPY1R (0.52) | GHSRNPY1RNPY2RNPY4R | |
| SCHEMBL30506405 | 0.88 | GHSR (0.54) | GHSR | |
| SCHEMBL31022136 | 0.88 | ERAP2 (0.56) | ECE1 | |
| SCHEMBL30799784 | 0.87 | GHSR (0.57) | GHSR | |
| SCHEMBL31259940 | 0.87 | ACE (0.57) | ECE1 | |
| SCHEMBL31259938 | 0.87 | ACE (0.57) | ECE1 | |
| SCHEMBL29577528 | 0.87 | ACE (0.57) | ECE1 | |
| SCHEMBL30628987 | 0.87 | ACE (0.57) | ECE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240116985-A1 | STAPLED PEPTIDES AND METHODS THEREOF | PARABILIS MEDICINES, INC. | 2024-04-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240116985-A1 | STAPLED PEPTIDES AND METHODS THEREOF | CTNNB1, APC, CTNNA1 | GHSR 1194/4885ECE1 1922/4885NPY1R 249/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.